The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Open accessAbstract
We analysed whole-genome sequences of 560 breast cancers to advance understanding of the driver mutations conferring clonal advantage and the mutational processes generating somatic mutations. We found that 93 protein-coding cancer genes carried probable driver mutations. Some non-coding regions exhibited high mutation frequencies, but most have distinctive structural features probably causing elevated mutation rates and do not contain driver mutations. Mutational signature analysis was extended to genome rearrangements and revealed twelve base substitution and six rearrangement signatures. Three rearrangement signatures, characterized by tandem duplications or deletions, appear associated with defective homologous-recombination-based DNA repair: one with deficient BRCA1 function, another with deficient BRCA1 or BRCA2 function, the cause of the third is unknown. This analysis of all classes of somatic mutation across exons, introns and intergenic regions highlights the repertoire of cancer genes and mutational processes operating, and progresses towards a comprehensive account of the somatic genetic basis of breast cancer. Whole-genome sequencing of tumours from 560 breast cancer cases provides a comprehensive genome-wide view of recurrent somatic mutations and mutation frequencies across both protein coding and non-coding regions; several mutational signatures in these cancer genomes are associated with BRCA1 or BRCA2 function and defective homologous-recombination-based DNA repair. This study reports whole-genome sequencing of tumours and normal tissue from 560 breast cancer cases, providing a comprehensive genome-wide view of recurrent somatic mutations and mutation frequencies across both protein coding and non-coding regions. The authors analyse mutational signatures in these cancer genomes, including a new investigation of rearrangement mutational processes, and find several that are associated with BRCA1 or BRCA2 function and defective homologous-recombination-based DNA repair. They also find mutational signatures showing distinct DNA replication strand biases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, BRCA inactivation is known to promote genomic instability through homologous recombination deficiencies in several solid tumors such as breast and ovarian cancer.47”
From Evolution of Multiple Myeloma from a Genomic Perspective (2026) · cites this paper as [47]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Indeed, some mutational footprints were found to be associated with BRCA1/2 deficiency, namely deletions with flanking microhomology, as well as several “mutational signatures” including two COSMIC single nucleotide variant (SNV) signatures and two structural variant (SV) signatures8.”
From Pan-cancer landscape of homologous recombination deficiency. (2020) · cites this paper as [8]
In the citing paper
“These genomic features in the SCAN-B TNBC cohort were comparable to a previously reported WGS cohort8”
From Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study (2019) · cites this paper as [8]
In the citing paper
“Five substitution and five rearrangement signatures [8, 9] were identified”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Seventy-nine out of the 93 previously identified BC driver genes [9] were mutated”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Despite the role of TP53, ATM and CHEK2 in DNA-damage signalling and double-strand breaks detection, these tumours do not show evidence of BRCA-deficient signatures, as previously described [9, 13, 19], but instead they harbour highly complex clustered chromosomal rearrangements.”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“The variant was not reported in gnomAD or in the 560 BC genomes cohort [9] and is described by ClinVar (Variation ID: 135816) as ‘Class 3 Uncertain significance’”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Loss of function of BRCA1, BRCA2 and PALB2 yield a high mutation burden and specific signatures inferring defective HR [7, 9, 10, 13].”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“These clustered events coincided with amplifications of known BC oncogenes (e.g. ZNF217, ERBB2, CCND1, MYC) [9]”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Self-citationNishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Self-citationVelvet: Algorithms for de novo short read assembly using de Bruijn graphsPreprint
Zerbino, D. R., & Birney, E. (2008) · Genome Research · doi:10.1101/gr.074492.107 · Cited by 9,575
Self-citationThe genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Self-citationConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Wilkerson, M. D., & Hayes, D. N. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq170 · Cited by 5,645
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Cited by
Sorted by citations
Items 501–600 of 1,002
Analytical demands to use whole-genome sequencing in precision oncology
Meggendorfer, M., Jobanputra, V., Wrzeszczyński, K. O., Roepman, P., de Bruijn, E., Cuppen, E. P. J. G., Büttner, R., Caldas, C., Grimmond, S. M., Mullighan, C. G., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.009 · Cited by 51
Self-citationGenomic characterisation of hormone receptor-positive breast cancer arising in very young women
Luen, S. J., Viale, G., Nik‐Zainal, S., Savas, P. S., Kammler, R., Dell’Orto, P., Biasi, O., Degasperi, A., Brown, L. C., Láng, I., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2023.01.009 · Cited by 52
Self-citationLindholm, E. M., Aure, M. R. R., Haugen, M. H., Sahlberg, K. K., Kristensen, V. N., Nebdal, D. J. H., Børresen‐Dale, A., Lingjærde, O. C., & Engebraaten, O. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12561 · Cited by 51
Self-citationLarsson, C., Ehinger, A., Winslow, S., Leandersson, K., Klintman, M., Dahl, L., Vallon‐Christersson, J., Häkkinen, J., Hegardt, C., Manjer, J., et al. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-0170-2 · Cited by 52
Self-citationGuardians of the Genome: BRCA2 and Its Partners
Le, H. P., Heyer, W., & Liu, J. (2021) · Genes · doi:10.3390/genes12081229 · Cited by 55
Emerging role of oncogenic long noncoding RNA as cancer biomarkers
Aprile, M., Costa, V., Cimmino, A., & Călin, G. A. (2022) · International Journal of Cancer · doi:10.1002/ijc.34282 · Cited by 51
Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer
Santarpia, L., Bottai, G., Kelly, C. M., Győrffy, B., Székely, B., & Pusztai, L. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0369 · Cited by 59
Tan, Y., Chen, Y., Du, M., Peng, Z., & Xie, P. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.09.013 · Cited by 51
Vallon‐Christersson, J., Häkkinen, J., Hegardt, C., Saal, L. H., Larsson, C., Ehinger, A., Lindman, H., Olofsson, H., Sjöblom, T., Wärnberg, F., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48570-x · Cited by 50
Self-citationWhole genome sequencing of breast cancer
Rossing, M., Sørensen, C. S., Ejlertsen, B., & Nielsen, F. C. (2019) · Apmis · doi:10.1111/apm.12920 · Cited by 52
A comprehensive review of scaffolding methods in genome assembly
Luo, J., Wei, Y., Lyu, M., Wu, Z., Liu, X., Luo, H., & Yan, C. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab033 · Cited by 50
Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma
Kancherla, V., Abdullazade, S., Matter, M. S., Lanzafame, M., Quagliata, L., Roma, G., Hoshida, Y., Terracciano, L., Ng, C. K. Y., & Piscuoglio, S. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00002 · Cited by 50
CRTC 1– MAML 2 fusion in mucoepidermoid carcinoma of the breast
Bean, G. R., Krings, G., Otis, C. N., Solomon, D. A., García, J. J., van Zante, A., Camelo-Piragua, S. I., Ziffle, J. V., & Chen, Y.-Y. (2018) · Histopathology · doi:10.1111/his.13779 · Cited by 50
Multiplex ddPCR assay for screening copy number variations in BRCA1 gene
Oscorbin, I. P., Андреевич, К. А., Boyarskikh, U. A., & Филипенко, М. Л. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05425-3 · Cited by 51
Learning mutational signatures and their multidimensional genomic properties with TensorSignatures
Vöhringer, H. S., van Hoeck, A., Cuppen, E. P. J. G., & Gerstung, M. (2021) · Nature Communications · doi:10.1038/s41467-021-23551-9 · Cited by 48
Self-citationERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas
Deniziaut, G., Tille, J. C., Bidard, F., Vacher, S., Schnitzler, A., Chemlali, W., Trémoulet, L., Fuhrmann, L., Cottu, P. H., Rouzier, R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11819 · Cited by 49
Self-citationChen, X., Zhang, G., Chen, B., Wang, Y., Guo, L., Cao, L., Ren, C., Wen, L., & Liao, N. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108997 · Cited by 46
Kim, M., Xi, H., & Park, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252181 · Cited by 49
Maclachlan, K. H., Rustad, E. H., Derkach, A., Zheng-Lin, B., Yellapantula, V., Diamond, B., Hultcrantz, M., Ziccheddu, B., Boyle, E. M., Blaney, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25469-8 · Cited by 49
Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers
Setton, J. S., Hadi, K., Choo, Z.-N., Kuchin, K. S., Tian, H., Paula, A. D. C., Rosiene, J. A., Selenica, P., Behr, J. M., Yao, X., et al. (2023) · Nature · doi:10.1038/s41586-023-06461-2 · Cited by 47
Aldea, M. D., Friboulet, L., Apcher, S., Jaulin, F., Mosele, F., Sourisseau, T., Soria, J., Nikolaev, S. I., & André, F. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.101642 · Cited by 52
Mitochondrial DNA damage, repair, and replacement in cancer
Vodička, P., Vodenková, S., Danesova, N., Vodičková, L., Zobalová, R., Tomášová, K., Boukalová, Š., Berridge, M. V., & Neužil, J. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.09.010 · Cited by 50
Kawazu, M., Kojima, S., Ueno, T., Totoki, Y., Nakamura, H. K., Kunita, A., Qü, W., Yoshimura, J., Soda, M., Yasuda, T., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006853 · Cited by 48
P-Rex1 and P-Rex2 RacGEFs and cancer
Srijakotre, N., Man, J., Ooms, L. M., LUCATO, C. M. A., Ellisdon, A. M., & Mitchell, C. A. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160269 · Cited by 48
Luen, S. J., Asher, R., Lee, C. K., Savas, P. S., Kammler, R., Dell’Orto, P., Biasi, O., Demanse, D., JeBailey, L., Dolan, S., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.1778 · Cited by 48
Computational approaches for discovery of mutational signatures in cancer
Baez‐Ortega, A., & Gori, K. C. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx082 · Cited by 48
The molecular genetic make-up of male breast cancer
Moelans, C. B., de Ligt, J., van der Groep, P., Prins, P., Besselink, N. J. M., Hoogstraat, M., ter Hoeve, N. D., Laclé, M. M., Kornegoor, R., van der Pol, C. C., et al. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0278 · Cited by 47
Self-citationHammerl, D., Massink, M. P. G., Smid, M., van Deurzen, C. H. M., Meijers-Heijboer, H. E. J., Waisfisz, Q., Debets, R., & Martens, J. W. M. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0285 · Cited by 46
Self-citationIncreased activation of PI3 kinase-δ predisposes to B-cell lymphoma
Durandy, A., & Kracker, S. (2020) · Blood · doi:10.1182/blood.2019002072 · Cited by 50
Eckelmann, B. J., Bacolla, A., Wang, H., Ye, Z., Guerrero, E. N., Jiang, W., El‐Zein, R. A., Hegde, M. L., Tomkinson, A. E., Tainer, J. A., et al. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa013 · Cited by 49
The genomic landscape of metastatic histologic special types of invasive breast cancer
Pareja, F. G., Ferrando, L., Lee, S., de Beça, F. F., Selenica, P., Brown, D. N., Farmanbar, A., Paula, A. D. C., Vahdatinia, M., Zhang, H., et al. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-00195-4 · Cited by 47
New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer
Conteduca, V., Mosca, A., Brighi, N., Giorgi, U. D., & Rescigno, P. (2021) · Cells · doi:10.3390/cells10010193 · Cited by 52
Mouron, S. A., Manso, L., Caleiras, E. J., Rodríguez‐Peralto, J. L., Rueda, O. M., Caldas, C., Colomer, R., Quintela-Fandiño, M., & Bueno, M. J. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01398-8 · Cited by 50
Self-citationMomen, S., Fassihi, H., Davies, H. R., Nikolaou, C., Degasperi, A., Stefanato, C. M., Dias, J. M. L., Dasgupta, D., Craythorne, E. E., Sarkany, R., et al. (2019) · Molecular Case Studies · doi:10.1101/mcs.a004408 · Cited by 48
Self-citationPaulson, T. G., Galipeau, P. C., Oman, K. M., Sanchez, C. A., Kuhner, M. K., Smith, L. P., Hadi, K., Shah, M. J., Arora, K. S., Shelton, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29767-7 · Cited by 47
Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer
Carpenter, M. A., Temiz, N. A., Ibrahim, M. A.-A., Jarvis, M. C., Brown, M. R., Argyris, P. P., Brown, W. L., Starrett, G. J., Yee, D., & Harris, R. S. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1011043 · Cited by 48
EXO1 protects BRCA1-deficient cells against toxic DNA lesions
van de Kooij, B., Schreuder, A., Pavani, R., Garzero, V., Uruci, S., Wendel, T. J., van Hoeck, A., Alonso, M. S. M., Everts, M., Koerse, D., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2023.12.039 · Cited by 49
Saturation genome editing-based clinical classification of BRCA2 variants
Sahu, S., Galloux, M., Southon, E. A., Caylor, D., Sullivan, T. L., Arnaudi, M., Zanti, M., Geh, J., Chari, R., Michailidou, K., et al. (2025) · Nature · doi:10.1038/s41586-024-08349-1 · Cited by 48
Proteasome dysregulation in human cancer: implications for clinical therapies
Chen, Y., Zhang, Y., & Guo, X. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9704-y · Cited by 51
CNV Detection from Circulating Tumor DNA in Late Stage Non-Small Cell Lung Cancer Patients
Peng, H., Lŭ, L., Zhou, Z., Liu, J., Zhang, D., Nan, K., Zhao, X., Li, F., Tian, L., Hua, D., et al. (2019) · Genes · doi:10.3390/genes10110926 · Cited by 49
Nederlof, I., Bortoli, D. D., Barèche, Y., Nguyen, B., de Maaker, M., Hooijer, G. K. J., Buisseret, L., Kok, M., Smid, M., den Eynden, G. G. G. M. V., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1239-4 · Cited by 46
Self-citationUsing next‐generation sequencing to redefineBRCAnessin triple‐negative breast cancer
Lin, P., Chen, M., Tsai, L., Lo, C., Yen, T., Huang, T. Y., Chen, C., Fan, S., Kuo, S., & Huang, C. (2020) · Cancer Science · doi:10.1111/cas.14313 · Cited by 46
Recent Advances in Diagnostic and Therapeutic Approaches for Breast Cancer: A Comprehensive Review
Noor, F., Noor, A., Ishaq, A. R., Farzeen, I., Saleem, M. H., Ghaffar, K., Aslam, M. F., Aslam, S., & Chen, J. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210303141416 · Cited by 55
Extreme purifying selection against point mutations in the human genome
Dukler, N., Mughal, M. R., Ramani, R., Huang, Y.-F., & Siepel, A. C. (2022) · Nature Communications · doi:10.1038/s41467-022-31872-6 · Cited by 49
Comprehensive pharmacogenomic characterization of gastric cancer
Sa, J. K., Hong, J. Y., Lee, I.-K., Kim, J.-S., Sim, M.-H., Kim, H. J., An, J. Y., Sohn, T. S., Lee, J. H., Bae, J. M., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-0717-8 · Cited by 46
Self-citationAPOBEC3 mutagenesis drives therapy resistance in breast cancer
Gupta, A., Gazzo, A. M., Selenica, P., Safonov, A. M., Pareja, F. G., da Silva, E. M., Brown, D. N., Shao, H., Zhu, Y., Patel, J., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02187-1 · Cited by 51
TERT promoter hotspot mutations in breast cancer
Shimoi, T., Yoshida, M., Kitamura, Y., Yoshino, T., Kawachi, A., Shimomura, A., Noguchi, E., Yunokawa, M., Yonemori, K., Shimizu, C., et al. (2017) · Breast Cancer · doi:10.1007/s12282-017-0825-5 · Cited by 47
Chen, Z., Wen, W., Beeghly-Fadiel, A. C., Shu, X., Díez‐Obrero, V., Long, J., Bao, J., Wang, J., Liu, Q., Cai, Q., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.07.006 · Cited by 43
New generation breast cancer cell lines developed from patient-derived xenografts
Finlay-Schultz, J., Jacobsen, B. M., Riley, D., Vinod-Paul, K., Turner, S. A., Ferreira‐Gonzalez, A., Harrell, J. C., Kabos, P., & Sartorius, C. A. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01300-y · Cited by 46
Integrated molecular drivers coordinate biological and clinical states in melanoma
Conway, J. R., Dietlein, F., Taylor-Weiner, A. N., AlDubayan, S. H., Vokes, N. I., Keenan, T. E., Reardon, B. M., He, M. X., Margolis, C. A., Weirather, J. L., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00739-1 · Cited by 44
Patsouris, A., Diop, K., Trédan, O., Nenciu, D., Gonçalvès, A., Arnedos, M., Sablin, M., Jézéquel, P., Jimenez, M., Droin, N. M., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.09.028 · Cited by 46
Schwartz, C. J., Brogi, E., Marra, A., Paula, A. D. C., Nanjangud, G. J., da Silva, E. M., Patil, S., Shah, S., Ventura, K., Razavi, P., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00931-6 · Cited by 46
Structural variants shape driver combinations and outcomes in pediatric high-grade glioma
Dubois, F. P. B., Shapira, O., Greenwald, N. F., Zack, T. I., Wala, J. A., Tsai, J. W., Crane, A., Baguette, A., Hadjadj, D., Harutyunyan, A. S., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00403-z · Cited by 42
Self-citationHeijink, A. M., Stok, C., Porubskỳ, D., Manolika, E. M., de Kanter, J. K., Kok, Y. P., Everts, M., de Boer, H. R., Audrey, A., Bakker, F. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34519-8 · Cited by 51
Chen, D., Gervai, J. Z., Póti, Á., Németh, E., Szeltner, Z., Szikriszt, B., Gyüre, Z., Zámborszky, J., Ceccon, M., di Fagagna, F. D., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27872-7 · Cited by 47
Self-citationWitz, A., Dardare, J., Betz, M., Michel, C., Husson, M., Gilson, P., Merlin, J., & Harlé, A. (2025) · Biomarker Research · doi:10.1186/s40364-025-00740-y · Cited by 52
Bringing 3D tumor models to the clinic – predictive value for personalized medicine
Halfter, K., & Mayer, B. (2017) · Biotechnology Journal · doi:10.1002/biot.201600295 · Cited by 48
Targeting DNA repair: the genome as a potential biomarker
Nesic, K., Wakefield, M. J., Kondrashova, O., Scott, C. L., & McNeish, I. A. (2017) · The Journal of Pathology · doi:10.1002/path.5025 · Cited by 47
Agarwal, I., & Przeworski, M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1900714116 · Cited by 41
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
Rubanova, Y., Shi, R., Harrigan, C. F., Li, R., Wintersinger, J. A., Sahin, N., Deshwar, A. G., PCAWG Evolution and Heterogeneity Working Group, Dentro, S. C., Leshchiner, I., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14352-7 · Cited by 45
Self-citationBatalini, F., Gulhan, D., Mao, V. Y., Tran, A. V., Polak, M. M., Xiong, N., Tayob, N., Tung, N., Winer, E. P., Mayer, E. L., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0749 · Cited by 50
Self-citationSaha, D., Ryan, K. R., Lakkaniga, N. R., Acharya, B., Garcia, N. G., Smith, E. L., & Frett, B. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02167 · Cited by 44
Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures
Diamond, B. T., Ziccheddu, B., Maclachlan, K. H., Taylor, J., Boyle, E. M., Ossa, J. A., Jahn, J., Affer, M., Totiger, T. M., Coffey, D. G., et al. (2023) · Blood · doi:10.1182/blood.2022018244 · Cited by 47
Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4
Sowalsky, A. G., Kissick, H. T., Gerrin, S. J., Schaefer, R. J., Xia, Z., Russo, J. W., Arredouani, M. S., Bubley, G. J., Sanda, M. G., Li, W., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2414 · Cited by 44
Dao, P., Kim, Y.-A., Wójtowicz, D., Madan, S., Sharan, R., & Przytycka, T. M. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005695 · Cited by 43
Xia, L., Li, Z., Zhou, B., Tian, G., Zeng, L., Dai, H., Li, X., Liu, C., Lu, S., Xu, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06106-1 · Cited by 46
Matissek, K. J., Onozato, M. L., Sun, S., Zheng, Z., Schultz, A., Lee, J., Patel, K., Jerevall, P.-L., Saladi, S. V., Macleay, A., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0535 · Cited by 44
Self-citationTranscriptomic response of breast cancer cells to anacardic acid
Schultz, D. J., Krishna, A., Vittitow, S. L., Alizadeh‐Rad, N., Muluhngwi, P., Rouchka, E. C., & Klinge, C. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-26429-x · Cited by 44
Girnius, N., Edwards, Y. J. K., Garlick, D. S., & Davis, R. J. (2018) · eLife · doi:10.7554/elife.36389 · Cited by 45
The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer
Barry, P. A., Vatsiou, A. I., Spiteri, I., Nichol, D., Cresswell, G. D., Acar, A., Trahearn, N., Hrebien, S., García-Murillas, I., Chkhaidze, K., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3374 · Cited by 43
Li, G., Guo, X., Chen, M., Tang, L., Jiang, H., Day, J. X., Xie, Y., Peng, L., Xu, X., Li, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203495 · Cited by 44
Karaayvaz, M., Silberman, R. E., Langenbucher, A., Saladi, S. V., Ross, K. N., Zarcaro, E., Desmond, A. J., Yıldırım, M., Vivekanandan, V., Ravichandran, H., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay2611 · Cited by 42
Venet, D., Fimereli, D., Rothé, F., Boeckx, B., Maetens, M., Majjaj, S., Rouas, G., Capra, M. C., Bonizzi, G., Contaldo, F., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102793 · Cited by 44
Self-citationGenome-wide mutational signatures revealed distinct developmental paths for human B cell lymphomas
Ye, X., Ren, W., Liu, D., Li, X., Li, W., Wang, X., Meng, F., Yeap, L.-S., Hou, Y., Zhu, S., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200573 · Cited by 46
HPV Meets APOBEC: New Players in Head and Neck Cancer
Riva, G., Albano, C., Gugliesi, F., Pasquero, S., Pacheco, S. F. C., Pecorari, G., Landolfo, S., Biolatti, M., & Dell’Oste, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031402 · Cited by 44
Deciphering the signaling network of breast cancer improves drug sensitivity prediction
Tognetti, M., Gábor, A., Yang, M., Cappelletti, V., Windhager, J., Rueda, O. M., Charmpi, K., Esmaeilishirazifard, E., Bruna, A., de Souza, N., et al. (2021) · Cell Systems · doi:10.1016/j.cels.2021.04.002 · Cited by 42
Self-citationXu, J., Reznik, E., Lee, H.-J., Gundem, G., Jonsson, P., Sarungbam, J., Bialik, A., Sanchez-Vega, F., Creighton, C. J., Hoekstra, J., et al. (2019) · eLife · doi:10.7554/elife.38986 · Cited by 43
Self-citationGonçalvès, A., Bertucci, F., Guillé, A., Garnier, S., Adélaı̈de, J., Carbuccia, N., Cabaud, O., Finetti, P., Brunelle, S., Piana, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12714 · Cited by 43
Bieg-Bourne, C. C., Millis, S. Z., Piccioni, D. E., Fanta, P. T., Goldberg, M. E., Chmielecki, J., Parker, B. A., & Kurzrock, R. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1569 · Cited by 43
The estrogen receptor/GATA3/FOXA1 transcriptional network: lessons learned from breast cancer
Martin, E. M., Orlando, K. A., Yokobori, K., & Wade, P. A. (2021) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.05.015 · Cited by 43
Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing
He, J., Zeng, Z., Wang, Y., Deng, J., Tang, X., Liu, F., Huang, J., Chen, H., Liang, R., Zan, X., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01468-7 · Cited by 40
Transcriptomic and genomic features of invasive lobular breast cancer
Desmedt, C., Zoppoli, G. M., Sotiriou, C. P., & Salgado, R. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.007 · Cited by 43
Self-citationFunctionally Null RAD51D Missense Mutation Associates Strongly with Ovarian Carcinoma
Rivera, B., Iorio, M. R. D., Frankum, J. R., Nadaf, J., Fahiminiya, S., Arcand, S. L., Burk, D. L., Grapton, D., Tomiak, E. M., Hastings, V., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0190 · Cited by 42
CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis
Aftab, A., Shahzad, S., Hussain, H. M. J., Khan, R., Irum, S., & Tabassum, S. (2018) · Breast Cancer · doi:10.1007/s12282-018-0894-0 · Cited by 43
Replication stress response in cancer stem cells as a target for chemotherapy
Manic, G., Sistigu, A., Corradi, F., Musella, M., Maria, R. D., & Vitale, I. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.08.003 · Cited by 42
Wang, D., Gendoo, D. M. A., Ben‐David, Y., Woodgett, J. R., & Zacksenhaus, E. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1098-z · Cited by 42
Block, I., Müller, C., Sdogati, D., Pedersen, H., List, M., jaskot, A., Syse, S. D., Hansen, P. L., Schmidt, S., Christiansen, H., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0739-0 · Cited by 43
Wu, L., Huang, X., Kuang, Y., Xing, Z., Deng, X., & Luo, Z. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s209947 · Cited by 43
Chromatin interactome mapping at 139 independent breast cancer risk signals
Beesley, J., Sivakumaran, H., Marjaneh, M. M., Lima, L. G., Hillman, K. M., Kaufmann, S., Tuano, N., Hussein, N., Ham, S., Mukhopadhyay, P., et al. (2020) · Genome biology · doi:10.1186/s13059-019-1877-y · Cited by 41
Self-citationSinha, S., Mitchell, K. A., Zingone, A., Bowman, E. D., Sinha, N., Schäffer, A. A., Lee, J. S., Ruppin, E., & Ryan, B. M. (2020) · Nature Cancer · doi:10.1038/s43018-019-0009-7 · Cited by 42
Self-citationJung, C. K., Jung, S., Jeon, S., Jeong, Y. M., Kim, Y., Lee, S., Bae, J. S., & Chung, Y. (2020) · Thyroid · doi:10.1089/thy.2019.0459 · Cited by 43
Damasceno, J. D., Reis-Cunha, J. L., Crouch, K., Beraldi, D., Lapsley, C. T., Tosi, L. R. O., Bartholomeu, D. C., & McCulloch, R. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008828 · Cited by 41
Homologous Recombination Deficiency Testing for BRCA-Like Tumors: The Road to Clinical Validation
Ladan, M. M., van Gent, D. C., & Jager, A. (2021) · Cancers · doi:10.3390/cancers13051004 · Cited by 45
Guffanti, F., Alvisi, M. F., Anastasia, A., Ricci, F., Chiappa, M., Llop‐Guevara, A., Serra, V., Fruscio, R., Degasperi, A., Nik‐Zainal, S., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01609-1 · Cited by 43
Self-citationPan-cancer analysis reveals technical artifacts in TCGA germline variant calls
Buckley, A. R., Standish, K. A., Bhutani, K., Ideker, T. E., Lasken, R. S., Carter, H. K., Harismendy, O., & Schork, N. J. (2017) · BMC Genomics · doi:10.1186/s12864-017-3770-y · Cited by 43
Talsania, K., Shen, T.-W., Chen, X., Jaeger, E. B., Li, Z., Chen, Z., Chen, W., Tran, B. Q., Kusko, R. L., Wang, L., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02816-6 · Cited by 40
Rausch, T., Snajder, R., Léger, A., Simovic-Lorenz, M., Giurgiu, M., Villacorta, L., Henssen, A. G., Fröhling, S., Stegle, O., Birney, E., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100281 · Cited by 38
Self-citationDodge, A. E., LeBlanc, D., Zhou, G., Williams, A., Meier, M., Van, P., Lo, F. Y., Valentine, C., Salk, J., Yauk, C., et al. (2023) · bioRxiv · doi:10.1007/s00204-023-03527-y · Cited by 40
Global impact of somatic structural variation on the cancer proteome
Chen, F., Zhang, Y., Chandrashekar, D. S., Varambally, S., & Creighton, C. J. (2023) · Nature Communications · doi:10.1038/s41467-023-41374-8 · Cited by 46
O’Neill, K., Pleasance, E., Fan, J., Akbari, V., Chang, G., Dixon, K., Csizmók, V., MacLennan, S., Porter, V., Galbraith, A., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100674 · Cited by 47
Metadata
- Authors
- Nik-Zainal, S., Davies, H., Staaf, J., Ramakrishna, M., Glodzik, D., Zou, X., Martincorena, I., Alexandrov, L. B., Martin, S., Wedge, D. C., Van Loo, P., Ju, Y. S., Smid, M., Brinkman, A. B., Morganella, S., Aure, M. R., Lingjærde, O. C., Langerød, A., Ringnér, M., Ahn, S.-M., Boyault, S., Brock, J. E., Broeks, A., Butler, A., Desmedt, C., Dirix, L., Dronov, S., Fatima, A., Foekens, J. A., Gerstung, M., Hooijer, G. K. J., Jang, S. J., Jones, D. R., Kim, H.-Y., King, T. A., Krishnamurthy, S., Lee, H. J., Lee, J.-Y., Li, Y., McLaren, S., Menzies, A., Mustonen, V., O’Meara, S., Pauporté, I., Pivot, X., Purdie, C. A., Raine, K., Ramakrishnan, K., Rodríguez-González, F. G., Romieu, G., Sieuwerts, A. M., Simpson, P. T., Shepherd, R., Stebbings, L., Stefansson, O. A., Teague, J., Tommasi, S., Treilleux, I., Van den Eynden, G. G., Vermeulen, P., Vincent-Salomon, A., Yates, L., Caldas, C., Veer, L. V., Tutt, A., Knappskog, S., Tan, B. K. T., Jonkers, J., Borg, Å., Ueno, N. T., Sotiriou, C., Viari, A., Futreal, P. A., Campbell, P. J., Span, P. N., Van Laere, S., Lakhani, S. R., Eyfjord, J. E., Thompson, A. M., Birney, E., Stunnenberg, H. G., van de Vijver, M. J., Martens, J. W. M., Børresen-Dale, A.-L., Richardson, A. L., Kong, G., Thomas, G., & Stratton, M. R.
- Affiliations
- Wellcome Sanger Institute (GB)
- Lund University (SE)
- Los Alamos National Laboratory (US)
- Erasmus MC (NL)
- Radboud University Nijmegen (NL)
- European Bioinformatics Institute (GB)
- Oslo University Hospital (NO)
- University of Oslo (NO)
- Gachon University Gil Medical Center (KR)
- Centre Léon Bérard (FR)
- Brigham and Women's Hospital (US)
- The Netherlands Cancer Institute (NL)
- Université Libre de Bruxelles (BE)
- University of Antwerp (BE)
- Dana-Farber Cancer Institute (US)
- Amsterdam UMC Location University of Amsterdam (NL)
- Asan Medical Center (KR)
- Hanyang University (KR)
- Memorial Sloan Kettering Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Institut National du Cancer (FR)
- Inserm (FR)
- Ninewells Hospital (GB)
- Institut Regional du Cancer de Montpellier (FR)
- The University of Queensland (AU)
- Istituto Tumori Bari (IT)
- University of Cambridge (GB)
- Institute of Cancer Research (GB)
- Haukeland University Hospital (NO)
- Singapore General Hospital (SG)
- Institut national de recherche en sciences et technologies du numérique (FR)
- Radboud University Medical Center (NL)
- University of Iceland (IS)
- Corresponding author
- Viari, Alain
- Kong, Gu
- Stratton, Michael R.
- ORCID
- Davies, Helen
- Staaf, Johan
- Ramakrishna, Manasa
- Zou, Xueqing
- Alexandrov, Ludmil B.
- Martin, Sancha
- Wedge, David C.
- Ju, Young Seok
- Smid, Marcel
- Brinkman, Arie B.
- Morganella, Sandro
- Aure, Miriam R.
- Lingjærde, Ole Christian
- Ringnér, Markus
- Ahn, Sung-Min
- Boyault, Sandrine
- Brock, Jane E.
- Broeks, Annegien
- Desmedt, Christine
- Dirix, Luc
- Dronov, Serge
- Gerstung, Moritz
- Hooijer, Gerrit K. J.
- Jang, Se Jin
- Jones, David R.
- Krishnamurthy, Savitri
- Lee, Hee Jin
- Lee, Jeong-Yeon
- Li, Yilong
- McLaren, Stuart
- Menzies, Andrew
- Mustonen, Ville
- Pivot, Xavier
- Purdie, Colin A.
- Raine, Keiran
- Ramakrishnan, Kamna
- Rodríguez-González, F. Germán
- Sieuwerts, Anieta M.
- Simpson, Peter T.
- Shepherd, Rebecca
- Teague, Jon
- Tommasi, Stefania
- Treilleux, Isabelle
- Vermeulen, Peter
- Yates, Lucy
- Caldas, Carlos
- Veer, Laura van’t
- Tutt, Andrew
- Knappskog, Stian
- Tan, Benita Kiat Tee
- Jonkers, Jos
- Borg, Åke
- Ueno, Naoto T.
- Sotiriou, Christos
- Viari, Alain
- Futreal, P. Andrew
- Span, Paul N.
- Lakhani, Sunil R.
- Thompson, Alastair M.
- Birney, Ewan
- Stunnenberg, Hendrik G.
- Martens, John W. M.
- Richardson, Andrea L.
- Kong, Gu
- Thomas, Gilles
- Stratton, Michael R.
- Venue
- Nature
- Published
- 2016-05-02
- Volume
- 534
- Issue
- 7605
- Pages
- 47-54
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4910866
- OpenAlex
- W2344657883
- Semantic Scholar
- abb27e35f11dcd60325f42f270b7811a4e852852
- Cited by
- 2,218
- References
- 60
- Citations by year
- 2026: 125 · 2025: 147 · 2024: 178 · 2023: 271 · 2022: 212 · 2021: 293 · 2020: 288 · 2019: 241 · 2018: 200 · 2017: 181 · 2016: 78
- FWCI
- 97.22
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-01-18)
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- PubMed Central (acceptedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Apollo
- Funders
- U.S. Department of Energy (DE-AC52-06NA2-5396, AC52-06NA25396)
- Breast Cancer Research Foundation
- Dana-Farber/Harvard Cancer Center (P50 CA168504)
- University of Dundee
- Wellcome Trust (088177, 077012/Z/05/Z, 100183, 077012, WT100183MA, 098051)
- Francis Crick Institute (10202)
- QIMR Berghofer Medical Research Institute
- Cancer Research UK (60098573, 20952, CB4140, 16942)
- National Institute for Health and Care Research (NF-SI-0515-10090, NF-SI-0611-10154)
- Breast Cancer Campaign
- University of Cambridge
- European Commission (242006)
- National Research Foundation
- Icelandic Centre for Research
- Fonds De La Recherche Scientifique - FNRS
- Cancerfonden
- Cambridge University Hospitals (RG51913)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- National Research Foundation of Korea (2015R1A2A1A10052578, 2011-0030105)
- Vetenskapsrådet
- Háskóli Íslands
- Institut National Du Cancer
- Rannís
- National Institutes of Health (DE-AC52-06NA25396)
- National Nuclear Security Administration (DEAC52- 06NA25396)
- National Cancer Institute (CA168504, P30CA008748, P50CA168504)
- Los Alamos National Laboratory (AC52-06NA25396, DE-AC52-06NA25396)
- FP7 Ideas: European Research Council (322737)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- breast cancer, somatic mutations, driver mutations, mutational signatures, tandem duplication, homologous recombination deficiency, BRCA1, BRCA2, non-coding regions, intronic variants
- MeSH terms
- Breast Neoplasms, DNA Mutational Analysis, DNA Replication, DNA, Neoplasm, Female, Humans, Male, Mutation, Oncogenes, Cohort Studies, Genome, Human, Mutagenesis, Genes, BRCA1, Genomics, Genes, BRCA2, Mutation Rate, Recombinational DNA Repair
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
